Invitation to participate in a European, prospective multicenter study endorsed by UEG and ESNM on the assessment of gastrointestinal symptoms of Sars-Cov-2 infection (GI-COVID19).
We are inviting you to participate in a European, prospective multicenter study endorsed by UEG and ESNM on the assessment of gastrointestinal symptoms of Sars-Cov-2 infection (GI-COVID19).
A variable proportion of patients develop gastrointestinal symptoms, often as an initial or only manifestation of COVID-19. This may not surprise if one thinks that 48% of infected patients excretes SARS-Cov2 in feces and the gastrointestinal tract. Also, intestinal epithelial cells abundantly express ACE-2, the receptors that the SARS-Cov2 utilizes to gain access into the cell. These data suggest that the GI tract could be a primary site of infection and symptom development.
We are excited to share an exciting new initiative from Neurogastroenterology and Motility, which serves as the official journal for both the ESNM and ANMS. The journal will publish a set of guidelines papers, position statements and consensus documents every year in an initiative supported by the publisher.
Submission is a competitive process and a pre-proposal needs to be submitted in the following format (click here to download) (very brief) which will be sent to the appropriate society for their approval before being forwarded and reviewed by all the editors at the journal. Proposals which include authors both from USA and Europe will be viewed more favorably. The position papers are not limited to clinical topics but also basic science topics. As an e.g. “models for visceral pain measurement” was one such proposal. Feel free to reach out to us (firstname.lastname@example.org) if you have any additional questions about the pre-proposal.
If you are interested we would highly recommend you submit a pre-proposal to ESNM (Magdalena Mara at email@example.com) by April 30th 2020. If the topic of the pre-proposal is approved by ESNM it will be forwarded to Dr. Stephen Vanner, the Editor-in-Chief of the Neurogastroenterology and Motility. If the pre-proposal is then approved by the journal, the authors will receive an “invitation” to prepare the paper using the procedures and format described in the invitation. Specific submission deadlines will also be included. The paper will then be reviewed by experts in the field along with the editors of the journal. Even with approval of your pre-proposal the final acceptance and publication of the paper is not guaranteed unless it meets the high standards of the journal.
G. Barbara -President ESNM
All physical persons holding or training for a PhD or MD who are interested in gastrointestinal motility and neurophysiology of the gut are eligible as members to ESNM.
The Gut Microbiota & Health is an initiative of the ESNM to reasearch the booming area of Gut Microbiota, and their role on human health.
The European Society of Neurogastroenterology and Motility ESNM is composed of a Steering Committee and a General Assembly.
phone: +43 1 405 13 83 31
office: Alser Strasse 4, 1090 Vienna
Use of this website constitutes acceptance of the User Agreement, the General Terms and Conditions and the Data Protection Statement.